“We have entered the most challenging phase, ready to take on the market.” MCD (Micro Channel Devices) has officially entered the “Early Growth” phase. A passage that coincides, also symbolically, with a relay between LIFTT and Equiter, investor & advisor in the infrastructure, research and innovation sector that will support
“The electrophysiological signals from this study are remarkable and represent the strongest signals of engagement of the initial trial target that our laboratory has seen in the field of autism.”Stalicla, a Swiss clinical stage biotechnology company, announced the highly successful completion of phase 1b studies for its drug STP1. The
On April 5, 2022, automotive industry leader Alexander Hitzinger was appointed to the board of Electra Vehicles, Inc. as an independent board member. The appointment marks another milestone for the growing AI battery software startup as the company expands its roster of leading experts in the electric vehicle industry.Hitzinger has
The evolution of teaching, the advent of the DAD, the complexity and breadth of the training proposal and the need for constant adaptation to an extremely changing reality, are the premises that gave birth to Maieutical Labs, the start-up on which LIFTT has focused for some time and that focuses
VAT n. 12013790014
Shared Capital
€ 100.835.954,00 authorised,
€ 43.482.552,00 paid,
€ 40.000.000,00 as per last statutory financial statements.
LIFTT S.p.A. adopts an Organization, Management and Control Model in line with the provisions of Legislative Decree 231/2001, and the Code of Ethics as completing part of the Model.